Literature DB >> 12897101

Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease.

Noriyuki Sakata1, Akiko Noma, Yuji Yamamoto, Kouji Okamoto, Jing Meng, Shigeo Takebayashi, Ryoji Nagai, Seikoh Horiuchi.   

Abstract

BACKGROUND: Calcification of the media of arteries is common in patients with end-stage renal disease (ESRD) undergoing haemodialysis and is a major cause of arteriosclerosis. The aim of this study was to clarify the role of glycoxidative modification of elastin in the calcification of aortic media in this group of patients.
METHODS: Samples of tunica media were obtained from non-atherosclerotic areas of the aortas of cadavers of seven non-diabetic patients with ESRD (age 65.5 +/- 10.6 years) and 10 age-matched controls (age 61.1 +/- 10.3 years). The localization of pentosidine, a major glycoxidation product, and calcium deposits in the media were examined using immunohistochemical and von Kossa staining, followed by orcein staining for elastin fibres. Tissue levels of pentosidine and calcium were measured in elastase-digested media using reversed high-performance liquid chromatography and atomic absorption spectrophotometry, respectively.
RESULTS: In aortic media, but not intima, immunostained pentosidine was observed along elastin fibres or in the extracellular spaces between them. Early calcification was manifest as small punctate calcified deposits along elastin fibres in the media. Advanced calcification was found as large, confluent calcified deposits in extracellular spaces between elastin fibres. Double staining showed co-localization of pentosidine and calcified deposits in the media. Both the staining density of pentosidine and calcification were more prominent in ESRD patients than in controls. The mean medial contents of both elastin-associated pentosidine and calcium were significantly higher in ESRD patients than in controls. In ESRD patients, the level of calcium in elastase-digested media correlated significantly with pentosidine levels, which increased in parallel with the duration of haemodialysis.
CONCLUSIONS: Our results indicate that glycoxidative modification of elastin in aortic media may be involved in the enhancement of medial calcification in ESRD patients on haemodialysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897101     DOI: 10.1093/ndt/gfg200

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  High plasma pentosidine level is accompanied with cardiovascular events in hemodialysis patients.

Authors:  Ryuichi Furuya; Hiromichi Kumagai; Toshio Miyata; Hirotaka Fukasawa; Shinsuke Isobe; Naoko Kinoshita; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2011-12-09       Impact factor: 2.801

Review 2.  Vascular calcification: pathophysiology and risk factors.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 3.  Polyphenol uses in biomaterials engineering.

Authors:  Amin Shavandi; Alaa El-Din Ahmed Bekhit; Pouya Saeedi; Zohreh Izadifar; Adnan A Bekhit; Ali Khademhosseini
Journal:  Biomaterials       Date:  2018-03-13       Impact factor: 12.479

4.  Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women.

Authors:  Carlos Iribarren; Malini Chandra; Catherine Lee; Gabriela Sanchez; Danny L Sam; Farima Faith Azamian; Hyo-Min Cho; Huanjun Ding; Nathan D Wong; Sabee Molloi
Journal:  Circ Cardiovasc Imaging       Date:  2022-03-15       Impact factor: 7.792

Review 5.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

6.  Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol.

Authors:  James P Chow; Dan T Simionescu; Harleigh Warner; Bo Wang; Sourav S Patnaik; Jun Liao; Agneta Simionescu
Journal:  Biomaterials       Date:  2012-10-24       Impact factor: 12.479

Review 7.  Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease.

Authors:  Z A Massy; C Mazière; S Kamel; M Brazier; G Choukroun; C Tribouilloy; M Slama; M Andrejak; J C Mazière
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

8.  Breast Arterial Calcification: a New Marker of Cardiovascular Risk?

Authors:  Carlos Iribarren; Sabee Molloi
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-02-03

9.  Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.

Authors:  Mathieu R Brodeur; Céline Bouvet; Sonia Bouchard; Simon Moreau; Jeanne Leblond; Denis Deblois; Pierre Moreau
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease.

Authors:  Christopher L Newman; Sharon M Moe; Neal X Chen; Max A Hammond; Joseph M Wallace; Jeffry S Nyman; Matthew R Allen
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.